U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced
Primary HTS Code
3004.90.9130
$4641.1M monthly imports
Compare All →
Ruling Age
12 years
Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly
The tariff classification of Gabapentin Tablets (CAS-60142-96-3), imported in dosage form, from India
N242494 June 7, 2013 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9130 Mr. Richard Philpott Blue Point Pharmaceuticals Laboratories Unit C, East Gate Business Park Building 1, Little Island Cork, Ireland RE: The tariff classification of Gabapentin Tablets (CAS-60142-96-3), imported in dosage form, from India Dear Mr. Philpott: In your letter dated May 29, 2013, you requested a tariff classification ruling. The subject product, Gabapentin, is a medicinal preparation in tablet form containing the active ingredient, Gabapentin. The product will be imported in dosage form in 600 mg and 800 mg tablets. It is indicated for the treatment of epilepsy and neuropathic pains. The applicable subheading for the Gabapentin Tablets in dosage form will be 3004.90.9130, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives." The rate of duty will be free.Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at (646) 733-3033. Sincerely, Thomas J. Russo Director National Commodity Specialist Division